Episurf Medical
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar! Conversion of convertibles in a nominal amount of SEK 37,519,480 to 833,766,222 Class B shares
Through the conversion, the number of Class B shares and votes in Episurf increases by 833,766,222, corresponding to a dilution effect of approximately 12.03 per cent of the shares and the votes respectively. Through the conversion, the share capital increases by SEK 8,337,662.22.
For further details, please contact:
Jens Andersson, CEO, Episurf Medical
Tel: +46 (0) 768 55 67 02
Email: jens.andersson@episurf.com
The information was submitted for publication, through the agency of the contact person set out above, at 19:30 CEST on 22 June, 2026.
About Episurf Medical AB
Episurf Medical is a property company with exposure to a diversified portfolio of property assets. The company's objective is to create value growth through the acquisition and management of Nordic properties. The company also has a medical technology business based on the individualised implant Episealer® and associated surgical instruments, which are used to treat cartilage injuries in joints. Episurf Medical's head office is located in Stockholm, Sweden.